Nrc Health (NRC) Cash & Equivalents (2010 - 2026)

Nrc Health (NRC) has 17 years of Cash & Equivalents data on file, last reported at $2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 1.8% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 1.8% YoY), and the FY2025 full-year result was $4.1 million, down 2.22% from the prior year.
• Cash & Equivalents retreated to $2.5 million in Q1 2026, from $4.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $47.3 million in Q1 2022 to a low of $485000.0 in Q2 2024.
• A 5-year average of $12.8 million and a median of $4.2 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 97.84% in 2024 and soared 987.42% in 2025, its largest moves.
• Tracing NRC's Cash & Equivalents over 5 years: stood at $25.0 million in 2022, then sank by 73.42% to $6.7 million in 2023, then tumbled by 36.37% to $4.2 million in 2024, then decreased by 2.22% to $4.1 million in 2025, then plunged by 38.46% to $2.5 million in 2026.
• Business Quant data shows NRC's Cash & Equivalents at $2.5 million in Q1 2026, $4.1 million in Q4 2025, and $2.2 million in Q3 2025.